Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 10—October 2024
Dispatch
Mpox Epidemiology and Vaccine Effectiveness, England, 2023
Table 1
Available demographic characteristics of mpox case-patients, England, 2022 and 2023*
Variable | Year, no, (%) |
|
---|---|---|
2022, n = 3,412† | 2023, n = 137 | |
Region | ||
London | 2,359 (69) | 105 (77.0) |
Outside London | 1,040 (30) | 32 (23.0) |
Unknown |
13 (0.4) |
0 |
Sex | ||
M | 3,345 (98) | 135 (99.0) |
F | 45 (1.3) | 1 (0.7) |
Unknown |
22 (0.6) |
1 (0.7) |
Sexual orientation GBMSM | 983 (97)‡ | 128 (93)§ |
*Patients were median 36 years of age for both years (IQR 30–44 y in 2022 and 29–43 y in 2023). IQR, interquartile range; GBMSM, gay, bisexual, men who have sex with men. †May 6–Sep 16, 2022 (1). ‡Obtained via enhanced surveillance questionnaires, which were complete for 31% of case-patients by September 18, 2022. §107 case-patients self-identified identifying as GBMSM plus 21 who were adult men without recorded information on sexual orientation and no travel to mpox-endemic countries in Central or West Africa but were presumed to be part of the outbreak.
References
- UK Health Security Agency. Monkeypox outbreak: technical briefing 8 [cited 2024 Feb 14]. https://www.gov.uk/government/publications/monkeypox-outbreak-technical-briefings/investigation-into-monkeypox-outbreak-in-england-technical-briefing-8
- UK Health Security Agency. Mpox (monkeypox) outbreak: epidemiological overview [cited 2024 Feb 14]. https://www.gov.uk/government/publications/monkeypox-outbreak-epidemiological-overview
- UK Health Security Agency. Mpox (monkeypox): case definitions [cited 2024 Feb 14]. https://www.gov.uk/guidance/monkeypox-case-definitions
- UK Health Security Agency. Reporting to UKHSA: a guide for diagnostic laboratories [cited 2024 Feb 14]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1159953/UKHSA_Laboratory_reporting_guidelines_May_2023.pdf
- UK Health Security Agency. Notifiable diseases and causative organisms: how to report [cited 2024 Feb 14]. https://www.gov.uk/guidance/notifiable-diseases-and-causative-organisms-how-to-report
- Flannery B, Andrews N, Feikin D, Patel MK. Commentary: Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 2023;52:19–21. DOIPubMedGoogle Scholar
- Bertran M, Andrews N, Davison C, Dugbazah B, Boateng J, Lunt R, et al. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Lancet Infect Dis. 2023;23:828–35. DOIPubMedGoogle Scholar
- UK Health Security Agency. HIV action plan monitoring and evaluation framework [cited 2024 Apr 25].[REMOVED HYPERLINKB0036ECA5C0100 FIELD] https://www.gov.uk/government/publications/hiv-monitoring-and-evaluation-framework
- Chicago Health Alert Network. Potential risk for new mpox cases—provider update: May 9, 2023 [cited 2024 Feb 14]. https://emergency.cdc.gov/han/2023/han00490.asp
- Chicago Department of Public Health. Mpox dashboard [cited 2024 Feb 14]. https://www.chicago.gov/city/en/depts/cdph/provdrs/infectious_disease/supp_info/mpox-home/mpox-dashboard.html
- World Health Organization. Multi-country outbreak of mpox: external situation report #31—22 December 2023 [cited 2024 Feb 14]. https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report-31---22-december-2023